Both in Pharmaceuticals
Arcutis Biotherapeutics vs Liquidia
Over the past year ARQT returned +29.2% and LQDA returned +67.3%; their daily moves had a correlation of 0.15.
ARQT +29.2% LQDA +67.3%Growth of $1, one year, split-adjusted
| Metric | ARQT | LQDA |
|---|---|---|
| Price | $32.00 | $42.20 |
| Market cap | $4.02B | $3.78B |
| Today | +2.37% | +0.84% |
| 1 month | +27.2% | +52.7% |
| 6 months | +36.6% | +5.2% |
| Year to date | +10.2% | +22.4% |
| 1 year | +26.4% | +73.2% |
| Revenue growth (YoY) | +59.3% | +1842.7% |
| Gross margin | 91.6% | 93.3% |
| Net margin | 11.6% | 43.5% |
| P/E (TTM) | 141.0× | 27.3× |
| Price / sales | 8.7× | 8.4× |
| Net cash | $129.7M | $108.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 189.7% |
| Short % of float | 18.0% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).